Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Archive of Events

<< 2010 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2012 >>

UCL Institute of Brand and Innovation Law (IBIL): Debate 2011

Start: Apr 6, 2011 6:00:00 PM
End: Apr 6, 2011 8:30:00 PM

ibil
Do Patents Incentivise or Inhibit Innovation?
A scientific and legal panel discussion

UCL Nanomedicine 2011

Start: Apr 11, 2011 9:30:00 AM

UCL
View Directions>>
Nanomedicine is the medical application of nanotechnology. The event is intended to showcase some of the applied research in nanomedicine ongoing at UCL.
<< 2010 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2012 >>